LONA
LeonaBio, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$89.71M
P/E Ratio
—
EPS
$-25.90
Beta
1.98
52W High
$14.21
52W Low
$2.30
50-Day MA
$8.45
200-Day MA
$5.56
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About LeonaBio, Inc.
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-33.21M |
| Operating Margin | 0.00% |
| Return on Equity | -290.80% |
| Return on Assets | -28.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.98 |
| Price-to-Book | 2.98 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $9.39M |
| Float | $6.41M |
| % Insiders | 4.46% |
| % Institutions | 68.70% |
Historical Volatility
HV 10-Day
65.91%
HV 20-Day
111.04%
HV 30-Day
109.64%
HV 60-Day
123.50%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($16.00 target)
2
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026